126 related articles for article (PubMed ID: 6684048)
1. The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
Paterson AG; Turkes A; Groom GV; Webster DJ
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):919-22. PubMed ID: 6684048
[TBL] [Abstract][Full Text] [Related]
2. Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer.
Fornander T; Rutqvist LE; Wilking N; Carlström K; von Schoultz B
Eur J Cancer; 1993; 29A(4):497-500. PubMed ID: 8435199
[TBL] [Abstract][Full Text] [Related]
3. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
[TBL] [Abstract][Full Text] [Related]
4. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
[No Abstract] [Full Text] [Related]
5. [The antiestrogen tamoxifen in advanced breast cancer (author's transl)].
Margreiter R
Langenbecks Arch Chir; 1980; 351(4):249-62. PubMed ID: 6779066
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum prolactin levels in advanced breast cancer.
Dowsett M; McGarrick GE; Harris AL; Coombes RC; Smith IE; Jeffcoate SL
Br J Cancer; 1983 Jun; 47(6):763-9. PubMed ID: 6860546
[TBL] [Abstract][Full Text] [Related]
7. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer.
Számel I; Vincze B; Hindy I; Hermann I; Borvendég J; Eckhardt S
Oncology; 1986; 43(1):7-11. PubMed ID: 3079899
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
Kiang DT; Kennedy BJ
Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women.
Helgason S; Wilking N; Carlström K; Damber MG; von Schoultz B
J Clin Endocrinol Metab; 1982 Feb; 54(2):404-8. PubMed ID: 6798066
[TBL] [Abstract][Full Text] [Related]
11. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?
Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH
Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer.
Corsello SM; Rota CA; Putignano P; Della Casa S; Barnabei A; Migneco MG; Vangeli V; Barini A; Mandalà M; Barone C; Barbarino A
Eur J Endocrinol; 1998 Sep; 139(3):309-13. PubMed ID: 9758441
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between prolactin and somatotropic hormone in human breast cancer].
Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
[TBL] [Abstract][Full Text] [Related]
14. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
Jordan VC; Fritz NF; Tormey DC
Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
[TBL] [Abstract][Full Text] [Related]
15. Plasma hormones in patients with advanced breast cancer treated with tamoxifen.
Golder MP; Phillips ME; Fahmy DR; Preece PE; Jones V; Henk JM; Griffiths K
Eur J Cancer (1965); 1976 Sep; 12(9):719-23. PubMed ID: 971694
[No Abstract] [Full Text] [Related]
16. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
[TBL] [Abstract][Full Text] [Related]
17. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
Love RR; Rose DR; Surawicz TS; Newcomb PA
Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
[TBL] [Abstract][Full Text] [Related]
18. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
Maddox PR; Jones DL; Mansel RE
Br J Cancer; 1992 Mar; 65(3):456-60. PubMed ID: 1558804
[TBL] [Abstract][Full Text] [Related]
20. Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
Wilking N; Carlström K; Sköldefors H; Theve NO; Wallgren A
Acta Chir Scand; 1982; 148(4):345-9. PubMed ID: 6215811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
